GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million
TAIPEI and SAN DIEGO, July 15, 2026 /PRNewswire/ -- GEM Global Yield LLC SCS ("GEM") has executed a Share Purchase Agreement (the "SPA") with the existing shareholders of Taiwan-listed Senhwa…
Read the full articleYou might also wanna read
Insider Sell: Sukumar Nagendran Sells 200,000 Shares of Taysha Gene Therapies Inc (TSHA)
Related Stocks: TSHA
Emcure Pharmaceuticals buys final 12.05% Gennova stake for ₹231.87 Crore to consolidate control.
Emcure Pharmaceuticals is acquiring the remaining 12.05% stake in Gennova Biopharmaceuticals for ₹231.87 Crore to reach 100% ownership. This
A turning point for pancreatic cancer patients
Eli Lilly announces two China deals, Akeso's lung cancer bispecific payoff, and more biotech news from The Readout
statnews.com·1mo ago
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
Emcure Pharma to Invest ₹231.87 Crore to Acquire 100% Control of Gennova Biopharmaceuticals
Emcure Pharmaceuticals moves from 87.95% to 100% ownership of Gennova Biopharmaceuticals for ₹231.87 crore, simplifying its corporate struct
Novartis to buy UK biotech in $1.5bn deal
Cancer-focused company was spun out from Imperial College and the Francis Crick Institute in 2019
Comments
Sign in to join the conversation.
No comments yet. Be the first.